Transcatheter aortic, mitral, and tricuspid therapies have emerged as important new therapy options for patients with valvular heart disease. Integrating non-invasive cardiac imaging, surgical experiences, and novel interventional approaches as part of a multidisciplinary heart team approach for diagnosis and planning of optimal treatment in complex patients with valvular heart disease.
Transcatheter Valve Therapies (TVT) is designed for interventional cardiologists, imaging specialists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals. TVT will provide a comprehensive review of the best clinical practices in the management of valvular heart disease, including in-depth coverage of less invasive transcatheter devices currently in use or under investigation.
- London, United Kingdom
- Chicago, Illinois
- San Francisco, California
- Buenos Aires, Argentina